Crohn's Disease

The chronic intestinal inflammation common in Crohn’s disease and ulcerative colitis appeared to increase the risk for type 2 diabetes, according to a study published in Clinical Gastroenterology and Hepatology.

Patients with Crohn’s disease are at higher risk for myocardial infarction than the general population, according to study results.

SAN DIEGO — Patients with Crohn’s disease treated with IV Entyvio demonstrated considerable improvements in quality of life and work productivity, according to a study presented at Digestive Disease Week.

SAN DIEGO — Discontinuing 5-aminosalicylate therapy after starting anti-TNF therapy did not heighten the risk for adverse clinical events among patients with Crohn’s disease, according to a study presented at Digestive Disease Week.

SAN DIEGO — The Crohn’s Disease Exclusion Diet appeared to be an effective and well-tolerated, first-line therapy for children with mild-to-moderate Crohn’s disease, according to data presented at Digestive Disease Week.

Healio Gastroenterology revealed its second annual Disruptive Innovators Awards recipients at the American College of Gastroenterology Annual Scientific Meeting.